Enterome vs ME Therapeutics Holdings
Enterome vs ME Therapeutics Holdings, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and ME Therapeutics Holdings on 28/100.
Where each one leads
Enterome
- our overall score: 60/100 against 28/100
- funding raised: $124M against $500K
ME Therapeutics Holdings
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Enterome | ME Therapeutics Holdings |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Biotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Healthcare, Pharmaceuticals, Cancer Research |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2012 | 2017 |
| Headquarters | Paris, France | Vancouver, Canada |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Enterome | ME Therapeutics Holdings |
|---|---|---|
| Employees | 33 | Not published |
| Total funding | $124M | $500K |
| Latest round | Later Stage VC | Private Placement |
| LinkedIn followers | 16,846 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | ME Therapeutics Holdings |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 28/100 |
| Traction | 55/100 | 28/100 |
| Team | 70/100 | Not published |
| Community | Not published | 14/100 |
| Search visibility | 34/100 | 17/100 |
| Quality | 68/100 | 35/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | Not published |
| Domain ratingLink authority, 0-100 | 46/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | ME Therapeutics Holdings |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Analytics 4, Segment | Not detected |
Enterome vs ME Therapeutics Holdings: common questions
Which is better, Enterome or ME Therapeutics Holdings?
On our 0-100 score Enterome rates higher (60/100 against 28/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Enterome and ME Therapeutics Holdings compare on the numbers?
Enterome leads on our overall score (60/100 against 28/100), funding raised ($124M against $500K).
Read the full Enterome review and pricing or the ME Therapeutics Holdings review and pricing. You can also browse other Enterome alternatives we track.